COVID-19 Vaccine Research Using UV Vis Spectrophotometry
White Paper

UV Vis Application in COVID-19 Vaccine

White Paper

Increasing Speed and Accuracy when Analyzing Vaccine Candidates and Their Components

This white paper shares how UV Vis spectrophotometry can facilitate the R&D of a COVID-19 vaccine.
This white paper shares how UV Vis spectrophotometry can facilitate the R&D of a COVID-19 vaccine.

A vaccine is a type of treatment aimed at stimulating the body’s immune system to fight against infectious pathogens such as bacteria and viruses. They are, according to the World Health Organization, “one of the most effective ways to prevent disease”.

This white paper offers an overview of in-process COVID-19 vaccine research and how UV/VIS Excellence spectrophotometers can increase speed and accuracy when characterizing vaccine candidates and their components.

UV Vis spectrophotometry provides fast, easy and accurate characterization of components such as nucleic acids (i.e. DNA/RNA), proteins, additives/preservatives, etc. and can impact the time-to-result for both downstream and upstream processes including quality control.

Download the white paper to know how UV Vis spectrophotometry can facilitate the R&D of a COVID-19 vaccine.

 

The METTLER TOLEDO ready-to-use applications available in the UV5Bio and UV5Nano are listed below. They have proven to be of significant benefit to the vaccine development process during research, upstream processing, downstream processing, and quality control. These applications are expected to play a role in the development of the COVID-19 vaccine as well.

 

This page is not optimized for your web browser. Consider using a different browser or upgrade your browser to the latest version to ensure the best experience.